Confidential Treatment has been requested for portions of this exhibit. The copy filed herewith omits the
information subject to the confidentiality request. Omissions are designated as “***”. A complete version of this
exhibit has been filed separately with the Securities and Exchange Commission.
COMMERCIAL LICENSE AGREEMENT
THIS AGREEMENT (“ Agreement ”) dated as of December 21, 2006 (“ Effective Date ”) is entered
into by and between SENESCO TECHNOLOGIES, INC, a Delaware corporation with principal offices at 303
George Street, Suite 420, New Brunswick, NJ 08901 (“ STI ”) and ARBORGEN, LLC, a Delaware limited
liability company with principle offices at 180 Westvaco Rd., Summerville, SC 29484 (“ AG ”).
WHEREAS, STI owns and controls technology, know-how and United States and foreign patents and
patent applications concerning methods for controlling plant senescence involving altering the expression of plant
genes and their cognate expressed proteins that are induced during or coincident with the onset of senescence;
WHEREAS, AG is a forestry biotech company in the business of research, development, and
commercialization of genetically improved trees;
WHEREAS, STI desires to grant to AG, and AG desires to obtain from STI, a commercial license under
the STI Technology (as defined herein) on the terms and conditions set forth in this Agreement.
NOW THEREFORE, in consideration of the premises and the faithful performance of the mutual
covenants hereinafter set forth, the parties hereto hereby agree as follows:
As used in this Agreement, the following defined terms shall have the respective meanings set forth below:
1.1 “ Affiliate ” means any entity which controls, is controlled by, or is under common control with another
entity. An entity is deemed to be in control of another entity (controlled entity) if such company directly
or indirectly owns 50% or more in nominal value of the issued equity sh